| Home / Health / News | Tools: Save | Print | E-mail | Most Read |
| Hepatitis B Therapeutic Vaccines Start Clinical Trials |
| Adjust font size: |
China has made great achievements in developing Hepatitis B Vaccines, with two therapeutic vaccines entering clinical research and trials. The Chinese newspaper People's Daily reported the good news for Hepatitis B patients, according to a source from the Chinese Ministry of Science and Technology. Once the new vaccines enter the market, they are expected to have unprecedented effects on Chinese people's health, elevating the cure rate for the disease. So far, China has 120 million Hepatitis B virus carriers. Meanwhile, 39 million patients suffer from chronic Hepatitis B. China has popularized the inoculation of Hepatitis B preventive vaccines in recent years; however, these vaccines do nothing to cure patients already infected with the virus. As of now, there is still no effective way to clear out the Hepatitis B virus from the bodies of patients, worldwide. However, the two new therapeutic vaccines may do more and further protect people from the disease. (CRI October 23, 2006) |
| Tools: Save | Print | E-mail | Most Read |
 |
| Related Stories |
|
